Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model.

Chen H, Zhu J.

Med Hypotheses. 2013 May;80(5):679-83. doi: 10.1016/j.mehy.2013.01.025. Epub 2013 Mar 13.

PMID:
23490201
2.

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.

Long S, Yang X, Liu X, Yang P.

PLoS One. 2012;7(12):e52381. doi: 10.1371/journal.pone.0052381. Epub 2012 Dec 21.

3.

MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.

Wu CY, Yang M, Lin M, Li LP, Wen XZ.

Arch Gynecol Obstet. 2013 Sep;288(3):595-605. doi: 10.1007/s00404-013-2721-3. Epub 2013 Mar 6.

PMID:
23463325
4.
5.

Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.

Xu XJ, Zou LW, Wang DB.

Mol Biol Rep. 2013 Jan;40(1):255-62. doi: 10.1007/s11033-012-2056-3. Epub 2012 Oct 16. Review.

PMID:
23070908
6.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
7.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
8.

The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis.

Mei Q, Zhou D, Gao J, Shen S, Wu J, Guo L, Liang Z.

BMC Cancer. 2012 Oct 11;12:467. doi: 10.1186/1471-2407-12-467. Review.

9.

MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Zhuo WL, Zhang L, Ling JJ, Zhu Y, Chen ZT.

Mol Biol Rep. 2012 Sep;39(9):8723-32. doi: 10.1007/s11033-012-1732-7. Epub 2012 Jun 19.

PMID:
22711309
10.

MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.

Sheng X, Zhang Y, Zhao E, Lu S, Zheng X, Ge H, Lu W.

Mol Biol Rep. 2012 Oct;39(10):9669-79. doi: 10.1007/s11033-012-1832-4. Epub 2012 Jun 23.

PMID:
22729883
11.

Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.

Yu L, Chang K, Han J, Deng S, Chen M.

PLoS One. 2013;8(2):e55835. doi: 10.1371/journal.pone.0055835. Epub 2013 Feb 19.

12.

Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis.

Wang H, Liu C.

Osteoporos Int. 2012 Nov;23(11):2625-34. doi: 10.1007/s00198-011-1885-6. Epub 2011 Dec 21.

PMID:
22187009
13.

Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Zhang Y, Chen GQ, Ji Y, Huang B, Shen WS, Deng LC, Xi L, Cao XM.

Mol Biol Rep. 2012 May;39(5):6203-11. doi: 10.1007/s11033-011-1439-1. Epub 2012 Jan 4.

PMID:
22215214
14.

Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, Zheng Q, Fu L, Du J.

Gene. 2013 Feb 10;514(2):105-11. doi: 10.1016/j.gene.2012.10.091. Epub 2012 Nov 29.

PMID:
23201418
15.

Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis.

Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L.

Cephalalgia. 2009 Aug;29(8):818-25. Epub 2007 Aug 21.

PMID:
17714520
16.
17.

Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.

Luo YL, Ye P, Zhang QH, Hu TT, Luo MH, Li MQ, Chen Q.

PLoS One. 2012;7(9):e46272. doi: 10.1371/journal.pone.0046272. Epub 2012 Sep 28.

19.

Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.

Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S, Donlon TA.

Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1275-80.

20.

Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.

Khandanpour N, Willis G, Meyer FJ, Armon MP, Loke YK, Wright AJ, Finglas PM, Jennings BA.

J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21. Review.

Supplemental Content

Support Center